Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1969 1
1971 2
1972 2
1973 2
1974 3
1976 2
1980 1
1981 1
1982 1
1983 2
1985 1
1986 2
1987 1
1993 1
1996 1
1997 2
1999 1
2001 3
2002 1
2003 1
2004 1
2006 2
2007 2
2008 3
2009 3
2010 1
2011 3
2012 1
2013 2
2014 3
2015 2
2016 1
2017 2
2018 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
Regulation of autophagy by stress-responsive transcription factors.
Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC, Kroemer G. Pietrocola F, et al. Semin Cancer Biol. 2013 Oct;23(5):310-22. doi: 10.1016/j.semcancer.2013.05.008. Epub 2013 May 30. Semin Cancer Biol. 2013. PMID: 23726895 Review.
In line with the critical role of autophagy in health and disease, defects in the autophagic machinery as well as in autophagy-regulatory signaling pathways have been associated with multiple human pathologies, including neurodegenerative disorders, autoimmune conditions a …
In line with the critical role of autophagy in health and disease, defects in the autophagic machinery as well as in autophagy-regulatory si …
Disseminated adenovirus infection after autologous stem cell transplant.
Kim NJ, Hyun TS, Pergam SA, Issaka RB. Kim NJ, et al. Transpl Infect Dis. 2020 Feb;22(1):e13238. doi: 10.1111/tid.13238. Epub 2020 Jan 7. Transpl Infect Dis. 2020. PMID: 31880047
Adenovirus is an infrequent but challenging viral complication of transplantation that is rarely reported after autologous stem cell transplant. We present a case of disseminated adenovirus infection in a woman who received an autologous stem cell transplant for tre …
Adenovirus is an infrequent but challenging viral complication of transplantation that is rarely reported after autologous stem cell …
Interleukin 35 and Hepatocyte Growth Factor; as a novel combined immune gene therapy for Multiple Sclerosis disease.
Moghadam S, Erfanmanesh M, Esmaeilzadeh A. Moghadam S, et al. Med Hypotheses. 2017 Nov;109:102-105. doi: 10.1016/j.mehy.2017.09.017. Epub 2017 Sep 22. Med Hypotheses. 2017. PMID: 29150266
An autoimmune demyelination disease of the Central Nervous System, Multiple Sclerosis, is a chronic inflammation which mostly involves young adults. ...In this hypothesis Interleukine-35 and Hepatocyte Growth Factor introduce to Mesenchymal Stem Cells of EAE mouse m …
An autoimmune demyelination disease of the Central Nervous System, Multiple Sclerosis, is a chronic inflammation which mostly …
Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis.
Sumaya CV, Myers LW, Ellison GW, Ench Y. Sumaya CV, et al. Ann Neurol. 1985 Apr;17(4):371-7. doi: 10.1002/ana.410170412. Ann Neurol. 1985. PMID: 2988410
The prevalence and titer of serum antibodies to several Epstein-Barr virus (EBV) antigens were compared among patients with multiple sclerosis, healthy siblings of multiple sclerosis patients, patients with other neurological diseases, and healthy non- …
The prevalence and titer of serum antibodies to several Epstein-Barr virus (EBV) antigens were compared among patients with multiple …
Beta-interferon protects multiple sclerosis patients against enhanced susceptibility to infections caused by poor air quality.
Oikonen MK, Erälinna JP. Oikonen MK, et al. Neuroepidemiology. 2008;30(1):13-9. doi: 10.1159/000113301. Epub 2008 Jan 17. Neuroepidemiology. 2008. PMID: 18204292
BACKGROUND: The monthly multiple sclerosis relapse rate was studied from January 1995 to March 2001 from hospital records in Southwestern Finland as a retrospective open-label study. ...PM(10) and virus infections had no significant effects in interferon user …
BACKGROUND: The monthly multiple sclerosis relapse rate was studied from January 1995 to March 2001 from hospital records in S …
Virus antibodies and multiple sclerosis.
Sever JL, Kurtzke JF, Alter M, Schumacher GA, Gilkeson MR, Ellenberg JH, Brody JA. Sever JL, et al. Arch Neurol. 1971 Jun;24(6):489-94. doi: 10.1001/archneur.1971.00480360023002. Arch Neurol. 1971. PMID: 4326199 No abstract available.
Adeno-Associated Virus Vectors and Stem Cells: Friends or Foes?
Brown N, Song L, Kollu NR, Hirsch ML. Brown N, et al. Hum Gene Ther. 2017 Jun;28(6):450-463. doi: 10.1089/hum.2017.038. Hum Gene Ther. 2017. PMID: 28490211 Free PMC article. Review.
The infusion of healthy stem cells into a patient-termed "stem-cell therapy"-has shown great promise for the treatment of genetic and non-genetic diseases, including mucopolysaccharidosis type 1, Parkinson's disease, multiple sclerosis, numerous immunodeficiency dis …
The infusion of healthy stem cells into a patient-termed "stem-cell therapy"-has shown great promise for the treatment of genetic and non-ge …
Oligodendrocyte injury in multiple sclerosis: a role for p53.
Wosik K, Antel J, Kuhlmann T, Brück W, Massie B, Nalbantoglu J. Wosik K, et al. J Neurochem. 2003 May;85(3):635-44. doi: 10.1046/j.1471-4159.2003.01674.x. J Neurochem. 2003. PMID: 12694389 Free article.
Multiple sclerosis (MS) is a neurological disorder characterized by myelin destruction and a variable degree of oligodendrocyte death. ...We investigated the mechanism of p53-induced apoptosis using primary cultures of central nervous system-derived adult human olig …
Multiple sclerosis (MS) is a neurological disorder characterized by myelin destruction and a variable degree of oligodendrocyt …
59 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page